Why Is Ascendis Pharma A/S $ASND Stock Down -11.92% Today? (Find out why any stock moved today on Tickeron.) • $ASND shares fell 11.92% in Tuesday's session, dropping to about $233.34 from a prior close of $264.92. • The selloff followed a Raymond James downgrade from Strong Buy to Outperform, even as the firm kept its $287 price target. • The move was triggered by Ascendis' decision to regain full rights to its TransCon metabolic and cardiovascular programs from Novo Nordisk (NVO). • A newly authorized $400 million share repurchase program signaled management confidence but failed to offset investor concerns about a longer, less certain path to value. • Traders are now watching how the reclaimed obesity and cardiovascular pipeline develops and whether near-term commercial momentum holds. $APGE $ARGX $ACLX $MLYS $RYTM $PCVX $CRNX